Abstract Body

We previously documented  a significantly higher prevalence (relative to comparable communities) of both primary language impairment (PLI) and language impairment concomitant with hearing/cognitive impairments (CLI) in perinatally HIV-infected (PHIV) and perinatally HIV-exposed uninfected (PHEU) participants (age range: 7-17y) from the Adolescent Master Protocol (AMP), a component of PHACS. This analysis describes longitudinal outcomes of this cohort to determine the persistence of PLI and CLI and associations with antiretroviral (ARV) treatment, disease status, and other risk factors.

The Clinical Evaluation of Language Fundamentals (CELF-4) was repeated on AMP participants 18 months after their baseline assessment. General linear regression models were utilized to identify independent predictors of change in standardized score (SC). The sample was also split by baseline status to LI (SC<85) and no LI (SC≥85), and separate logistic regression analyses were used to identify factors associated with the resolution or development of LI.

Complete language data at both time points were available on 319 participants (mean baseline age=12y, 80% black, 9% Hispanic). Among these, 112 (35%) had LI at baseline. Overall, SCs for the study population were highly stable and changes were similar in PHIV (n=212) and PHEU (n=107) participants. Family history of language delays/learning difficulties had a negative association with SC change after controlling for demographic and socioeconomic factors and baseline LI status (coefficient=-3.35, 95% CI: -5.83, -0.88). Among the PHIV group, being on combination antiretroviral treatment (cART) (4.50, CI: 0.31, 8.69) and high CD4 count (>350 cells/mm3) (4.61, CI: 0.48, 8.74) at baseline were associated with a higher mean SC change. Over the follow-up period, initial LI was persistent in the majority of cases (78%) and 21 new cases of LI occurred (10%). No significant risk factors for either developing or resolving LI were found among combined PHIV and PHEU after adjusting for demographics and baseline SC. Among PHIV, not being on cART at baseline was associated with lower odds of LI resolution (adj. Odds Ratio<0.01, CI: <0.01, 0.61) after controlling for demographics and baseline SC

Perinatally HIV exposed youth with LI are at risk for persistent LI, irrespective of infection status. Risk factors for declining scores included family history and–for PHIV–not receiving cART and low CD4 count.